Tagged Articles

Invokana side effects 23 articles

Number of Invokana side effects lawsuits growing in PA

Lawsuits alleging injuries caused by the type 2 diabetes drug Invokana are mounting across the country, but legal experts say they expect a large portion of them to come to Philadelphia because it is the home state of one of the manufacturers. At least 15 lawsuits have been filed in the Philadelphia Court of Common Please since December, court records show. The lawsuits blame Johnson & Johnson’s Janssen Pharmaceuticals and Mitsubishi Tanabe Pharmaceuticals for failing to warn the public of possible risks with Invokana. The lawsuits also claim that the medication is defectively designed because it does not allow the ... Read More

New Invokana side effects lawsuits filed in NJ federal court

Three lawsuits filed by patients alleging they suffered kidney damage and heart disease from Johnson & Johnson’s type 2 diabetes drug Invokana have been filed in federal court in New Jersey. The lawsuits name Johnson & Johnson, its subsidiary Janssen Pharmaceuticals, and Mitsubishi Tanabe Pharma Corp., the company that developed Invokana, as defendants. One of the lawsuits was filed on behalf of South Carolina resident Cornelius Benjamin. It claims Benjamin began taking Invokana to treat his diabetes in April 2013. He suffered a stroke and kidney damage, and died two months after beginning treatment with Invokana. Another lawsuit, filed by ... Read More

Invokana linked to ketoacidosis, bone fractures, bone density loss

Drugs from the newest class of type 2 diabetes treatments have been liked to a serious condition called ketoacidosis, in which too much acid builds up in the blood. Ketoacidosis requires immediate medical attention, and if left untreated can lead to diabetic coma or death. The class of drugs are known as sodium-glucose cotransporter-2 (SGLT2) inhibitors and include the brand-name medications Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance, Glyxambi. The first in the class, Invokana, was approved by the Food and Drug Administration (FDA) in 2013. SGLT2 inhibitors prevent high blood sugar by helping the kidneys remove excess sugar through urine. ... Read More